Related Experiment Video
Updated: Jun 10, 2025

09:10
An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
Published on: November 15, 2024
367
Contemporary Applications of Laser Interstitial Thermal Therapy: A Comprehensive Systematic Review
Margaret P Seaton1, Julia C Schmidt1, Nolan J Brown2
1School of Medicine, University of California, San Diego, California, USA.
World Neurosurgery
|October 17, 2024
Summary
Laser interstitial thermal therapy (LITT) is a safe and effective minimally invasive treatment for various brain conditions like tumors and epilepsy. This therapy offers significant benefits, especially for patients unsuitable for traditional surgery.
Area of Science:
- Neurosurgery
- Minimally Invasive Procedures
- Neurology
Background:
- Laser interstitial thermal therapy (LITT) is a minimally invasive neurosurgical technique.
- It is increasingly recognized for treating intracranial pathologies, especially those in difficult-to-access locations.
- LITT offers a less invasive alternative to open surgery for specific neurological conditions.
Purpose of the Study:
- To systematically review the evidence supporting current applications of LITT.
- To evaluate the safety and efficacy of LITT across various intracranial pathologies.
- To consolidate findings on LITT's role in treating brain tumors, radiation necrosis, and epilepsy.
Main Methods:
- Systematic review adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
- Searched three databases for studies reporting primary data on LITT applications.
- Included 39 studies involving 1533 patients meeting predefined eligibility criteria.
Main Results:
- LITT demonstrated safety and efficacy in treating brain tumors, radiation necrosis (RN), mesial temporal lobe epilepsy (MTLE), and cavernous malformations.
- It is particularly beneficial for patients ineligible for craniotomy.
- Specific benefits include improved survival in glioblastomas (up to 26 months), faster steroid cessation in RN, and comparable seizure control in MTLE versus anterior temporal lobectomy.
Conclusions:
- LITT is a safe and effective treatment option for brain tumors, RN, and MTLE.
- It provides significant advantages over traditional treatments for selected patient populations.
- Further research into emerging LITT applications may expand its use for central nervous system pathologies.

